Since it is a blinded trial and even the company has no idea how the drug is doing, shouldn't they now try to pay off the loan and have some money in the bank in case the trial does not succeed.
Imagine the shareprice if the RRR is 5%,...
Does anyone here think the company should cover all cases,...?